Skip to Main Content

Congressman Tom Price, President-elect Donald Trump’s nominee for secretary of health and human services, is doing what his prospective boss won’t: divesting financial interests in firms that could present a conflict of interest if he takes a role in the administration.

A letter dated Wednesday and addressed to an HHS ethics official lists 43 companies from which Price pledged to divest his interest within 90 days of his confirmation. Some, including Aetna, Amgen, Eli Lilly, and Pfizer, are major companies in the health care industry; others, including Amazon, Facebook, Delta Airlines, and Northrop Grumman, are not.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.